|
|
Who We Are
 Street
Advisors provides strategic advice to senior
management, boards of directors, private equity and
venture capital investors in rapidly growing or
early stage generic / specialty pharmaceutical
companies. Q Street’s expertise encompasses
European, Asian, and North American markets. Q
Street's scope of business includes:
 |
Business development and licensing deals involving branded and specialty pharmaceutical products and active pharmaceutical ingredient manufacturers
|
|
Strategic development and transactions to achieve growth or entry into markets in Europe, China, India, or the U.S. |
More than twenty years of
business development and management experience
in the pharmaceutical industry, including broad
experience in competitive, long-term strategy
development, active pharmaceutical ingredient
manufacturing and sourcing, product targeting
and international company expansion in the U.S.
market underpin Q Street Advisors’ expertise. Q
Street also has demonstrated experience in
China, Asia and Europe and extensive,
confidential relationships throughout the global
pharmaceutical industry.
Q Street Advisors was founded by pharmaceutical
industry veteran Jean Hoffman after selling
Newport Strategies,
a company she founded in 1990, to the Thomson
Corporation (NYSE: TOC).
|
|
|
|
